The WVU Cancer Institute is the first provider in the state to offer a new and promising treatment for extensive-stage small cell lung cancer. Extensive stage means the cancer has spread within the ...

Lung cancer remains the leading cause of cancer-related deaths globally, with cigarette smoking as its primary driver.

AstraZeneca announced that this week it has received two positive recommendations from the National Institute for Health and Care Excellence (NICE) for the treatment of lung cancer patients across ...

Research led by the Chiba Cancer Center Research Institute in Japan has discovered a surprising way cancer evades the immune ...

Adults with primary primary appendiceal adenocarcinoma face a higher risk of developing a second primary cancer, including ...

Vaccines are helpful in protecting against the flu and COVID-19, but could they also play a role in the fight against cancer?

Vaccines are helpful in protecting against the flu and COVID-19, but could they also play a role in the fight against cancer?

Lung cancer expert Triparna Sen delivered a seminar in the Cancer Biology Seminar Series at the University of Wisconsin Jan.

Copper chelation shows promising results in certain lung cancers where cells have two related phenomena: a heightened transcription factor responding to oxidative stress and a diminished level of ...

Researchers found that dual “off the shelf” stem cells designed to release an oncolytic virus and immune check point inhibitor improved survival in a model of leptomeningeal brain metastasis ...

Coherus markets LOQTORZI® (toripalimab-tpzi), a novel next-generation PD-1 inhibitor, and UDENYCA® (pegfilgrastim-cbqv), a biosimilar of Neulasta. In December 2024, Coherus announced the planned ...